Perphenazine (English Wikipedia)

Rees L (August 1960). "Chlorpromazine and allied phenothiazine derivatives". British Medical Journal. 2 (5197): 522–5. doi:10.1136/bmj.2.5197.522. PMC 2097091. PMID 14436902.
Ascher-Svanum H, Zhu B, Faries D, Landbloom R, Swartz M, Swanson J (February 2006). "Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia". BMC Psychiatry. 6 8. doi:10.1186/1471-244X-6-8. PMC 1402287. PMID 16504026.
King DJ (February 1998). "Drug treatment of the negative symptoms of schizophrenia". European Neuropsychopharmacology. 8 (1): 33–42. doi:10.1016/S0924-977X(97)00041-2. PMID 9452938. S2CID 37692796.
Lieberman JA (October 2006). "Comparative effectiveness of antipsychotic drugs. A commentary on: Cost Utility Of The Latest Antipsychotic Drugs In Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE)". Archives of General Psychiatry. 63 (10): 1069–72. doi:10.1001/archpsyc.63.10.1069. PMID 17015808.
Hartung B, Sampson S, Leucht S (March 2015). "Perphenazine for schizophrenia". The Cochrane Database of Systematic Reviews. 2015 (3) CD003443. doi:10.1002/14651858.CD003443.pub3. PMC 7173727. PMID 25749632.
Schillevoort I, de Boer A, Herings RM, Roos RA, Jansen PA, Leufkens HG (July 2001). "Antipsychotic-induced extrapyramidal syndromes. Risperidone compared with low- and high-potency conventional antipsychotic drugs". European Journal of Clinical Pharmacology. 57 (4): 327–31. doi:10.1007/s002280100302. hdl:1874/27881. PMID 11549212. S2CID 11934011.
Høyberg OJ, Fensbo C, Remvig J, Lingjaerde O, Sloth-Nielsen M, Salvesen I (December 1993). "Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations". Acta Psychiatrica Scandinavica. 88 (6): 395–402. doi:10.1016/S0149-2918(98)80046-5. PMID 7508675.
Moncrieff J (July 2006). "Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse". Acta Psychiatrica Scandinavica. 114 (1): 3–13. doi:10.1111/j.1600-0447.2006.00787.x. PMID 16774655. S2CID 6267180.
Sweet RA, Pollock BG, Mulsant BH, Rosen J, Sorisio D, Kirshner M, et al. (April 2000). "Pharmacologic profile of perphenazine's metabolites". Journal of Clinical Psychopharmacology. 20 (2): 181–7. doi:10.1097/00004714-200004000-00010. PMID 10770456.
Tardy M, Huhn M, Kissling W, Engel RR, Leucht S (July 2014). "Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia". The Cochrane Database of Systematic Reviews. 2014 (7) CD009268. doi:10.1002/14651858.CD009268.pub2. PMC 10898321. PMID 25007358.
Johanson CE, Kandel DA, Bonese K (1976). "The effects of perphenazine on self-administration behavior". Pharmacology, Biochemistry, and Behavior. 4 (4): 427–433. doi:10.1016/0091-3057(76)90059-9. PMID 819940.
Kapur S, Zipursky RB, Remington G, Jones C, Dasilva J, Wilson AA, et al. (1998). "5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: A PET investigation". The American Journal of Psychiatry. 155 (7): 921–928. doi:10.1176/ajp.155.7.921. PMID 9659858.
Gaitonde SA, Avet C, de la Fuente Revenga M, Blondel-Tepaz E, Shahraki A, Pastor AM, et al. (2024). "Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor". Molecular Psychiatry. 29 (9): 2753–2764. doi:10.1038/s41380-024-02531-7. PMC 11420065. PMID 38561467.
Sullivan LC, Clarke WP, Berg KA (2015). "Atypical Antipsychotics and Inverse Agonism at 5-HT2 Receptors". Current Pharmaceutical Design. 21 (26): 3732–3738. doi:10.2174/1381612821666150605111236. PMC 5543701. PMID 26044975.
Baksheeva VE, La Rocca R, Allegro D, Derviaux C, Pasquier E, Roche P, et al. (2025). "NanoDSF Screening for Anti-tubulin Agents Uncovers New Structure–Activity Insights". Journal of Medicinal Chemistry. doi:10.1021/acs.jmedchem.5c01008.
Jørgensen A, Overø KF (1980). "Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. III. Serum levels". Acta Psychiatrica Scandinavica. Supplementum. 279: 41–54. doi:10.1111/j.1600-0447.1980.tb07082.x. PMID 6931472.
Curry SH, Whelpton R, de Schepper PJ, Vranckx S, Schiff AA (April 1979). "Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man". British Journal of Clinical Pharmacology. 7 (4): 325–31. doi:10.1111/j.1365-2125.1979.tb00941.x. PMC 1429660. PMID 444352.
Beresford R, Ward A (January 1987). "Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis". Drugs. 33 (1): 31–49. doi:10.2165/00003495-198733010-00002. PMID 3545764.
Reyntigens AJ, Heykants JJ, Woestenborghs RJ, Gelders YG, Aerts TJ (1982). "Pharmacokinetics of haloperidol decanoate. A 2-year follow-up". International Pharmacopsychiatry. 17 (4): 238–46. doi:10.1159/000468580. PMID 7185768.

drugbank.com (Global: low place; English: low place)

go.drugbank.com

"Perphenazine".

handle.net (Global: 102^nd place; English: 76^th place)

hdl.handle.net

Schillevoort I, de Boer A, Herings RM, Roos RA, Jansen PA, Leufkens HG (July 2001). "Antipsychotic-induced extrapyramidal syndromes. Risperidone compared with low- and high-potency conventional antipsychotic drugs". European Journal of Clinical Pharmacology. 57 (4): 327–31. doi:10.1007/s002280100302. hdl:1874/27881. PMID 11549212. S2CID 11934011.

in.gov.br (Global: 3,151^st place; English: 5,932^nd place)

Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.

inist.fr (Global: 2,854^th place; English: 3,669^th place)

pascal-francis.inist.fr

Larsson M, Axelsson R, Forsman A (1984). "On the pharmacokinetics of perphenazine: a clinical study of perphenazine enanthate and decanoate". Current Therapeutic Research. 36 (6): 1071–88. INIST 8951670.

mind.org.uk (Global: low place; English: low place)

"Triptafen | Mind, the mental health charity - help for mental health problems". www.mind.org.uk. Retrieved 2017-03-19.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Rees L (August 1960). "Chlorpromazine and allied phenothiazine derivatives". British Medical Journal. 2 (5197): 522–5. doi:10.1136/bmj.2.5197.522. PMC 2097091. PMID 14436902.
Ascher-Svanum H, Zhu B, Faries D, Landbloom R, Swartz M, Swanson J (February 2006). "Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia". BMC Psychiatry. 6 8. doi:10.1186/1471-244X-6-8. PMC 1402287. PMID 16504026.
King DJ (February 1998). "Drug treatment of the negative symptoms of schizophrenia". European Neuropsychopharmacology. 8 (1): 33–42. doi:10.1016/S0924-977X(97)00041-2. PMID 9452938. S2CID 37692796.
Lieberman JA (October 2006). "Comparative effectiveness of antipsychotic drugs. A commentary on: Cost Utility Of The Latest Antipsychotic Drugs In Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE)". Archives of General Psychiatry. 63 (10): 1069–72. doi:10.1001/archpsyc.63.10.1069. PMID 17015808.
Hartung B, Sampson S, Leucht S (March 2015). "Perphenazine for schizophrenia". The Cochrane Database of Systematic Reviews. 2015 (3) CD003443. doi:10.1002/14651858.CD003443.pub3. PMC 7173727. PMID 25749632.
Schillevoort I, de Boer A, Herings RM, Roos RA, Jansen PA, Leufkens HG (July 2001). "Antipsychotic-induced extrapyramidal syndromes. Risperidone compared with low- and high-potency conventional antipsychotic drugs". European Journal of Clinical Pharmacology. 57 (4): 327–31. doi:10.1007/s002280100302. hdl:1874/27881. PMID 11549212. S2CID 11934011.
Høyberg OJ, Fensbo C, Remvig J, Lingjaerde O, Sloth-Nielsen M, Salvesen I (December 1993). "Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations". Acta Psychiatrica Scandinavica. 88 (6): 395–402. doi:10.1016/S0149-2918(98)80046-5. PMID 7508675.
Moncrieff J (July 2006). "Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse". Acta Psychiatrica Scandinavica. 114 (1): 3–13. doi:10.1111/j.1600-0447.2006.00787.x. PMID 16774655. S2CID 6267180.
Sweet RA, Pollock BG, Mulsant BH, Rosen J, Sorisio D, Kirshner M, et al. (April 2000). "Pharmacologic profile of perphenazine's metabolites". Journal of Clinical Psychopharmacology. 20 (2): 181–7. doi:10.1097/00004714-200004000-00010. PMID 10770456.
Tardy M, Huhn M, Kissling W, Engel RR, Leucht S (July 2014). "Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia". The Cochrane Database of Systematic Reviews. 2014 (7) CD009268. doi:10.1002/14651858.CD009268.pub2. PMC 10898321. PMID 25007358.
Johanson CE, Kandel DA, Bonese K (1976). "The effects of perphenazine on self-administration behavior". Pharmacology, Biochemistry, and Behavior. 4 (4): 427–433. doi:10.1016/0091-3057(76)90059-9. PMID 819940.
Kapur S, Zipursky RB, Remington G, Jones C, Dasilva J, Wilson AA, et al. (1998). "5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: A PET investigation". The American Journal of Psychiatry. 155 (7): 921–928. doi:10.1176/ajp.155.7.921. PMID 9659858.
Gaitonde SA, Avet C, de la Fuente Revenga M, Blondel-Tepaz E, Shahraki A, Pastor AM, et al. (2024). "Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor". Molecular Psychiatry. 29 (9): 2753–2764. doi:10.1038/s41380-024-02531-7. PMC 11420065. PMID 38561467.
McNeil SE, Gibbons JR, Cogburn M (2025). "Risperidone". StatPearls. PMID 29083663.
Sullivan LC, Clarke WP, Berg KA (2015). "Atypical Antipsychotics and Inverse Agonism at 5-HT2 Receptors". Current Pharmaceutical Design. 21 (26): 3732–3738. doi:10.2174/1381612821666150605111236. PMC 5543701. PMID 26044975.
Jørgensen A, Overø KF (1980). "Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. III. Serum levels". Acta Psychiatrica Scandinavica. Supplementum. 279: 41–54. doi:10.1111/j.1600-0447.1980.tb07082.x. PMID 6931472.
Ereshefsky L, Saklad SR, Jann MW, Davis CM, Richards A, Seidel DR (May 1984). "Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches". The Journal of Clinical Psychiatry. 45 (5 Pt 2): 50–9. PMID 6143748.
Curry SH, Whelpton R, de Schepper PJ, Vranckx S, Schiff AA (April 1979). "Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man". British Journal of Clinical Pharmacology. 7 (4): 325–31. doi:10.1111/j.1365-2125.1979.tb00941.x. PMC 1429660. PMID 444352.
Janssen PA, Niemegeers CJ, Schellekens KH, Lenaerts FM, Verbruggen FJ, van Nueten JM, et al. (November 1970). "The pharmacology of fluspirilene (R 6218), a potent, long-acting and injectable neuroleptic drug". Arzneimittel-Forschung. 20 (11): 1689–98. PMID 4992598.
Beresford R, Ward A (January 1987). "Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis". Drugs. 33 (1): 31–49. doi:10.2165/00003495-198733010-00002. PMID 3545764.
Reyntigens AJ, Heykants JJ, Woestenborghs RJ, Gelders YG, Aerts TJ (1982). "Pharmacokinetics of haloperidol decanoate. A 2-year follow-up". International Pharmacopsychiatry. 17 (4): 238–46. doi:10.1159/000468580. PMID 7185768.

ncbi.nlm.nih.gov

Rees L (August 1960). "Chlorpromazine and allied phenothiazine derivatives". British Medical Journal. 2 (5197): 522–5. doi:10.1136/bmj.2.5197.522. PMC 2097091. PMID 14436902.
Ascher-Svanum H, Zhu B, Faries D, Landbloom R, Swartz M, Swanson J (February 2006). "Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia". BMC Psychiatry. 6 8. doi:10.1186/1471-244X-6-8. PMC 1402287. PMID 16504026.
Hartung B, Sampson S, Leucht S (March 2015). "Perphenazine for schizophrenia". The Cochrane Database of Systematic Reviews. 2015 (3) CD003443. doi:10.1002/14651858.CD003443.pub3. PMC 7173727. PMID 25749632.
Tardy M, Huhn M, Kissling W, Engel RR, Leucht S (July 2014). "Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia". The Cochrane Database of Systematic Reviews. 2014 (7) CD009268. doi:10.1002/14651858.CD009268.pub2. PMC 10898321. PMID 25007358.
Gaitonde SA, Avet C, de la Fuente Revenga M, Blondel-Tepaz E, Shahraki A, Pastor AM, et al. (2024). "Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor". Molecular Psychiatry. 29 (9): 2753–2764. doi:10.1038/s41380-024-02531-7. PMC 11420065. PMID 38561467.
McNeil SE, Gibbons JR, Cogburn M (2025). "Risperidone". StatPearls. PMID 29083663.
Sullivan LC, Clarke WP, Berg KA (2015). "Atypical Antipsychotics and Inverse Agonism at 5-HT2 Receptors". Current Pharmaceutical Design. 21 (26): 3732–3738. doi:10.2174/1381612821666150605111236. PMC 5543701. PMID 26044975.
Curry SH, Whelpton R, de Schepper PJ, Vranckx S, Schiff AA (April 1979). "Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man". British Journal of Clinical Pharmacology. 7 (4): 325–31. doi:10.1111/j.1365-2125.1979.tb00941.x. PMC 1429660. PMID 444352.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

King DJ (February 1998). "Drug treatment of the negative symptoms of schizophrenia". European Neuropsychopharmacology. 8 (1): 33–42. doi:10.1016/S0924-977X(97)00041-2. PMID 9452938. S2CID 37692796.
Schillevoort I, de Boer A, Herings RM, Roos RA, Jansen PA, Leufkens HG (July 2001). "Antipsychotic-induced extrapyramidal syndromes. Risperidone compared with low- and high-potency conventional antipsychotic drugs". European Journal of Clinical Pharmacology. 57 (4): 327–31. doi:10.1007/s002280100302. hdl:1874/27881. PMID 11549212. S2CID 11934011.
Moncrieff J (July 2006). "Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse". Acta Psychiatrica Scandinavica. 114 (1): 3–13. doi:10.1111/j.1600-0447.2006.00787.x. PMID 16774655. S2CID 6267180.

unc.edu (Global: 1,538^th place; English: 1,042^nd place)

pdsp.med.unc.edu

National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Oct 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from: "PDSP Database - UNC". Archived from the original on 2013-11-08. Retrieved 2013-11-03.

web.archive.org (Global: 1^st place; English: 1^st place)

Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
National Institute of Mental Health. PDSD Ki Database (Internet) [cited 2013 Oct 3]. Chapel Hill (NC): University of North Carolina. 1998-2013. Available from: "PDSP Database - UNC". Archived from the original on 2013-11-08. Retrieved 2013-11-03.

Perphenazine (English Wikipedia)

books.google.com (Global: 3rd place; English: 3rd place)

doccheck.com (Global: 9,231st place; English: low place)

flexikon.doccheck.com

doi.org (Global: 2nd place; English: 2nd place)

drugbank.com (Global: low place; English: low place)

go.drugbank.com

handle.net (Global: 102nd place; English: 76th place)

hdl.handle.net

in.gov.br (Global: 3,151st place; English: 5,932nd place)

inist.fr (Global: 2,854th place; English: 3,669th place)

pascal-francis.inist.fr

mind.org.uk (Global: low place; English: low place)

nih.gov (Global: 4th place; English: 4th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

semanticscholar.org (Global: 11th place; English: 8th place)

api.semanticscholar.org

unc.edu (Global: 1,538th place; English: 1,042nd place)

pdsp.med.unc.edu

web.archive.org (Global: 1st place; English: 1st place)

books.google.com (Global: 3^rd place; English: 3^rd place)

doccheck.com (Global: 9,231^st place; English: low place)

doi.org (Global: 2^nd place; English: 2^nd place)

handle.net (Global: 102^nd place; English: 76^th place)

in.gov.br (Global: 3,151^st place; English: 5,932^nd place)

inist.fr (Global: 2,854^th place; English: 3,669^th place)

nih.gov (Global: 4^th place; English: 4^th place)

semanticscholar.org (Global: 11^th place; English: 8^th place)

unc.edu (Global: 1,538^th place; English: 1,042^nd place)

web.archive.org (Global: 1^st place; English: 1^st place)